ストックスクリーナーアプリを入手
18.94
0.53%
0.10
プレマーケット:
18.95
0.010
+0.05%
前日終値:
$18.84
開ける：
$19.14
24時間の取引高:
1.52M
Relative Volume:
0.97
時価総額：
$1.28B
収益：
$796.00M
当期純損益:
$-136.49M
株価収益率:
-9.0622
EPS:
-2.09
ネットキャッシュフロー:
$-64.24M
1週間 パフォーマンス:
-3.66%
1か月 パフォーマンス:
-6.05%
6か月 パフォーマンス:
+74.72%
1年 パフォーマンス:
-41.94%
1日の値動き範囲:
$18.45
$19.26
1週間の範囲:
$18.34
$19.81
52週間の値動き範囲:
$9.98
$35.12
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
名前
Tandem Diabetes Care Inc
セクター
電話
858-366-6900
住所
12400 HIGH BLUFF DRIVE, San Diego, CA
Compare TNDM vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
18.94 | 1.28B | 796.00M | -136.49M | -64.24M | -2.09 |
|
ABT
Abbott Laboratories
|
113.29 | 195.21B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
377.32 | 141.28B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
98.49 | 123.60B | 35.48B | 4.64B | 5.41B | 3.5856 |
|
BSX
Boston Scientific Corp
|
76.28 | 113.14B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.98 | 45.52B | 6.07B | 1.06B | 799.60M | 1.8527 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-27 | 再開されました | TD Cowen | Buy |
| 2025-12-16 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2025-10-21 | 再開されました | Stifel | Hold |
| 2025-09-08 | 開始されました | Oppenheimer | Outperform |
| 2025-08-12 | アップグレード | Citigroup | Sell → Neutral |
| 2025-08-07 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2025-07-09 | ダウングレード | Citigroup | Neutral → Sell |
| 2025-06-16 | 開始されました | Truist | Hold |
| 2025-04-10 | 開始されました | Mizuho | Neutral |
| 2025-03-05 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-04 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-03-03 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2025-02-28 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2024-12-02 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-06 | 開始されました | Bernstein | Outperform |
| 2024-10-04 | 開始されました | Goldman | Neutral |
| 2024-10-02 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-08-22 | 開始されました | Morgan Stanley | Equal-Weight |
| 2024-08-08 | 開始されました | Canaccord Genuity | Buy |
| 2024-05-30 | 開始されました | Redburn Atlantic | Buy |
| 2024-05-22 | アップグレード | Citigroup | Neutral → Buy |
| 2024-04-29 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-04-25 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2024-03-26 | アップグレード | Stifel | Hold → Buy |
| 2023-08-04 | ダウングレード | Citigroup | Buy → Neutral |
| 2023-05-05 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-04-24 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-03-29 | 開始されました | UBS | Neutral |
| 2023-01-26 | 開始されました | Wolfe Research | Peer Perform |
| 2022-11-15 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-08-09 | ダウングレード | Wells Fargo | Overweight → Underweight |
| 2022-03-02 | 再開されました | BofA Securities | Neutral |
| 2022-01-19 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2021-07-21 | 再開されました | Cowen | Outperform |
| 2021-05-25 | 開始されました | Barclays | Underweight |
| 2020-12-15 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-08-20 | 開始されました | Wells Fargo | Overweight |
| 2020-07-31 | アップグレード | Guggenheim | Neutral → Buy |
| 2020-07-06 | アップグレード | Citigroup | Neutral → Buy |
| 2020-06-18 | 繰り返されました | Raymond James | Outperform |
| 2020-04-24 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2020-03-23 | ダウングレード | Guggenheim | Buy → Neutral |
| 2020-03-05 | 開始されました | Citigroup | Neutral |
| 2020-02-06 | 開始されました | Raymond James | Outperform |
| 2020-02-04 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2019-10-18 | 開始されました | Guggenheim | Buy |
| 2019-10-04 | アップグレード | UBS | Neutral → Buy |
| 2019-05-17 | 繰り返されました | BofA/Merrill | Neutral |
| 2019-05-13 | 開始されました | SVB Leerink | Outperform |
| 2019-03-08 | 開始されました | BMO Capital Markets | Outperform |
| 2019-03-05 | 繰り返されました | BofA/Merrill | Neutral |
| 2019-02-27 | 繰り返されました | Lake Street | Buy |
| 2018-11-21 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2018-09-26 | 繰り返されました | Dougherty & Company | Buy |
| 2018-09-26 | 繰り返されました | Piper Jaffray | Overweight |
すべてを表示
Tandem Diabetes Care Inc (TNDM) 最新ニュース
Tandem Diabetes Care's Earnings Outlook - Benzinga
Assessing Tandem Diabetes Care (TNDM) Valuation After Recent Share Price Weakness - Yahoo Finance
Tandem Diabetes Care, Inc. (TNDM) Investor Outlook: Exploring A 37.96% Potential Upside - DirectorsTalk Interviews
Unlocking Q4 Potential of Tandem Diabetes Care (TNDM): Exploring Wall Street Estimates for Key Metrics - Yahoo Finance
Understanding Momentum Shifts in (TNDM) - Stock Traders Daily
Did t:slim X2 Legal Probe Just Shift Tandem Diabetes Care's (TNDM) Disclosure and Risk Narrative? - simplywall.st
Tandem Diabetes Care Announces Upcoming Conference PresentationsFebruary 12, 2026 - BioSpace
Tandem Diabetes Care (TNDM) to Release Earnings on Thursday - MarketBeat
Diabetes Care Devices Market to Reach USD 42.1 Billion by 2028, Growing at a 4.8% CAGR - industrytoday.co.uk
TNDM Investor News: If You Have Suffered Losses in Tandem - GlobeNewswire
Don't buy Tandem Diabetes Care until this big thing happens - MSN
Tandem Diabetes Care, Inc. (TNDM): Investor Outlook With A 38.40% Potential Upside - DirectorsTalk Interviews
Will Tandem Diabetes Care Inc. benefit from geopolitical trends2025 Key Highlights & Expert Verified Movement Alerts - mfd.ru
What’s the beta of Tandem Diabetes Care Inc. stockEarnings Summary Report & AI Enhanced Trading Signals - mfd.ru
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), ... - Bluefield Daily Telegraph
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors t - GuruFocus
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action InvestigationTNDM - PR Newswire
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Avoiding Lag: Real-Time Signals in (TNDM) Movement - Stock Traders Daily
Abbott on track with dual sensor, FDA warns on FreeStyle Libre - Modern Healthcare
Artificial Pancreas System Market is expected to reach US$ - openPR.com
Stifel Nicolaus Reaffirms Their Hold Rating on Tandem Diabetes Care (TNDM) - The Globe and Mail
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Breaking Down Tandem Diabetes Care: 12 Analysts Share Their Views - Benzinga
TNDM: Stifel Maintains Hold Rating, Raises PT to $20 | TNDM Stoc - GuruFocus
Stifel Nicolaus Issues Positive Forecast for Tandem Diabetes Care (NASDAQ:TNDM) Stock Price - MarketBeat
Assessing Tandem Diabetes Care (TNDM) Valuation After Recent Share Price Momentum Shift - Sahm
Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Exploring a 29% Potential Upside in the Medical Devices Sector - DirectorsTalk Interviews
United States Diabetes Devices Market to Reach US$ 19.44 Billion - openPR.com
Commit To Buy Tandem Diabetes Care At $13, Earn 14.2% Annualized Using Options - Nasdaq
Is Tandem Diabetes Care (TNDM) Starting To Look Attractive After Prolonged Share Price Weakness? - Yahoo Finance
Investment Review: Will Tandem Diabetes Care Inc stock benefit from M AJuly 2025 Price Swings & Stepwise Trade Signal Guides - baoquankhu1.vn
Energy Moves: Is Tandem Diabetes Care Inc forming bullish engulfing patternsWeekly Stock Analysis & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Can Tandem Diabetes Care Inc. generate free cash flowJuly 2025 Snapshot & Weekly Setup with High ROI Potential - mfd.ru
Why Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Could Be Worth Watching - 富途牛牛
Tandem Diabetes Care Inc (TNDM) Stock Price Down 4.17% on Jan 28 - GuruFocus
Pleasing Signs As A Number Of Insiders Buy Tandem Diabetes Care Stock - Yahoo Finance
Improved Growth Outlook and Better-Than-Expected Results Boosted Tandem Diabetes Care (TNDM) in Q4 - Insider Monkey
Rosen Law Firm Investigates Tandem Diabetes Securities Claims - Intellectia AI
TNDM Stock: TD Cowen Boosts Price Target and Reaffirms Buy Ratin - GuruFocus
Can Tandem Diabetes Care Inc stock double in the next yearInsider Selling & Weekly Setup with ROI Potential - baoquankhu1.vn
A Look At Tandem Diabetes Care (TNDM) Valuation After Legal Probe Into t:slim X2 Pump Correction - Sahm
Discipline and Rules-Based Execution in TNDM Response - Stock Traders Daily
3 Reasons to Avoid TNDM and 1 Stock to Buy Instead - Finviz
Analysts Have Conflicting Sentiments on These Healthcare Companies: Tandem Diabetes Care (TNDM), Qiagen (QGEN) and Siemens Healthineers AG (OtherSEMHF) - The Globe and Mail
TNDM INVESTOR NEWS: ROSEN, A LONGSTANDING FIRM, Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action InvestigationTNDM - marketscreener.com
How Device Correction and Securities Probe Will Impact Tandem Diabetes Care (TNDM) Investors - Sahm
Aug Reactions: Will Tandem Diabetes Care Inc benefit from geopolitical trendsJuly 2025 Levels & Fast Gain Swing Alerts - baoquankhu1.vn
Does Tandem Diabetes Care Inc. (TD5A) stock trade below intrinsic value2025 Market Trends & Technical Pattern Recognition Alerts - bollywoodhelpline.com
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action InvestigationTNDM - TMX Newsfile
Diabetes warning issued over insulin pump error - MSN
Tandem Diabetes Care Inc (TNDM) 財務データ
収益
当期純利益
現金流量
EPS
1.13%
大文字化:
|
ボリューム (24 時間):